121 filings
EFFECT
IVVD
Invivyd Inc
22 Apr 24
Notice of effectiveness
12:15am
ARS
2023 FY
IVVD
Invivyd Inc
18 Apr 24
Annual report to shareholders
4:15pm
DEF 14A
IVVD
Invivyd Inc
Definitive proxy
18 Apr 24
4:06pm
8-K
IVVD
Invivyd Inc
12 Apr 24
Invivyd Announces CEO Transition
7:36am
8-K
IVVD
Invivyd Inc
4 Apr 24
Invivyd Provides PEMGARDATM Launch Update and Announces 2024 Net Product
5:25pm
8-K
me84ij8uoa9xe
28 Mar 24
Invivyd Reports Full Year 2023 Financial Results and Recent Business Highlights
7:05am
8-K
9rxye5q7osfayi4hf
22 Mar 24
Invivyd Announces FDA Authorization for Emergency Use of PEMGARDAâ„¢ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19
8:58pm
8-K
a78fu1zoyacs mqo
9 Feb 24
Index to Consolidated Financial Statements
4:01pm
8-K
uyh3z9qsl
8 Jan 24
Other Events
7:12am
8-K
wfh z1i93l84454u7
3 Jan 24
Other Events
7:06am
8-K
dwwgc ng33272qv5elv
22 Dec 23
Entry into a Material Definitive Agreement
4:53pm
424B5
9fvfqpsvxr 75rs
22 Dec 23
Prospectus supplement for primary offering
4:51pm
8-K
tclhwa9 2mvdyt0
18 Dec 23
Invivyd Announces Positive Initial Results from Ongoing CANOPY Phase 3 Pivotal Clinical Trial
7:16am
8-K
k6es85c1f
9 Nov 23
Invivyd Reports Third Quarter 2023 Financial Results and Recent Business Highlights
4:10pm
8-K
bagvb3j7
11 Sep 23
Other Events
7:10am
8-K
ehu990i
5 Sep 23
Invivyd Appoints William Duke As Chief Financial Officer
7:05am